These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 36775822)
1. Seroprevalence of COVID-19 infection in a densely populated district in the eastern Democratic Republic of Congo. Irenge LM; Bulakali HM; Akonkwa AI; Ambroise J; Gala JL Epidemiol Infect; 2023 Feb; 151():e24. PubMed ID: 36775822 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of anti-SARS-CoV-2 antibodies in people attending the two main Goma markets in the eastern Democratic Republic of the Congo. Mitangala PN; Irenge LM; Musubao ET; Kahindo JBM; Ayonga PN; Kyembwa Safari I; Kubuya JB; Ntabe EN; Kabangwa Senga RK; Mutombo GN; Ambroise J; Gala JL Epidemiol Infect; 2023 Sep; 151():e167. PubMed ID: 37724000 [TBL] [Abstract][Full Text] [Related]
3. [Seroprevalence of SARS-CoV-2 antibodies among travellers and workers screened at the Saint Luc Clinic in Bukavu, a city in eastern Democratic Republic of the Congo, from May to August 2020]. Katchunga PB; Murhula A; Akilimali P; Zaluka JC; Karhikalembu R; Makombo M; Bisimwa J; Mubalama E Pan Afr Med J; 2021; 38():93. PubMed ID: 33889259 [TBL] [Abstract][Full Text] [Related]
4. High Prevalence of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (Anti-SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey. Nkuba AN; Makiala SM; Guichet E; Tshiminyi PM; Bazitama YM; Yambayamba MK; Kazenza BM; Kabeya TM; Matungulu EB; Baketana LK; Mitongo NM; Thaurignac G; Leendertz FH; Vanlerberghe V; Pelloquin R; Etard JF; Maman D; Mbala PK; Ayouba A; Peeters M; Muyembe JT; Delaporte E; Ahuka SM Clin Infect Dis; 2022 Mar; 74(5):882-890. PubMed ID: 34089598 [TBL] [Abstract][Full Text] [Related]
5. High SARS-CoV-2 Seroprevalence after Second COVID-19 Wave (October 2020-April 2021), Democratic Republic of the Congo. Munyeku-Bazitama Y; Folefack GT; Yambayamba MK; Tshiminyi PM; Kazenza BM; Otshudiema JO; Guinko NT; Umba MD; Mulumba A; Baketana LK; Mukadi PK; Smith C; Muyembe-Tamfum JJ; Ahuka-Mundeke S; Makiala-Mandanda S Emerg Infect Dis; 2023 Jan; 29(1):89-97. PubMed ID: 36573545 [TBL] [Abstract][Full Text] [Related]
6. High SARS-CoV-2 Seroprevalence in Healthcare Workers in Bukavu, Eastern Democratic Republic of Congo. Mukwege D; Byabene AK; Akonkwa EM; Dahma H; Dauby N; Cikwanine Buhendwa JP; Le Coadou A; Montesinos I; Bruyneel M; Cadière GB; Vandenberg O; Van Laethem Y Am J Trop Med Hyg; 2021 Feb; 104(4):1526-1530. PubMed ID: 33591936 [TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of anti-SARS-CoV-2 antibodies and risk of viral exposure among healthcare workers in the South Kivu province, eastern Democratic Republic of the Congo: a cross-sectional study. Chasinga TB; Cikwanine JB; Kribi S; Yoyu JT; Hofmann N; Grossegesse M; Nitsche A; Tomczyk S; Vietor AC; Leendertz FH; Eckmanns T; Kusinza AB; Munguakonkwa E; Kalk A; Raha M; Kambale NS; Ayagirwe RB; Schubert G; Mukwege D BMJ Open; 2024 Jan; 14(1):e072212. PubMed ID: 38176860 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441 [TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021. Raqib R; Sarker P; Akhtar E; Nurul Huda TM; Haq MA; Roy AK; Hosen MB; Haque F; Chowdhury MR; Reidpath DD; Emdadul Hoque DM; Islam Z; Ahmed S; Ahmed T; Tofail F; Razzaque A PLoS One; 2022; 17(5):e0268093. PubMed ID: 35604947 [TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 seroprevalence in vaccine-naïve participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali. Laverdure S; Kazadi D; Kone K; Callier V; Dabitao D; Dennis D; Haidara MC; Hunsberger S; Mbaya OT; Ridzon R; Sereti I; Shaw-Saliba K; Int J Infect Dis; 2024 May; 142():106985. PubMed ID: 38417612 [TBL] [Abstract][Full Text] [Related]
13. COVID-19 seroprevalence cohort survey among health care workers and their household members in Kinshasa, DR Congo, 2020-2022. Madinga J; Mbala-Kingebeni P; Nkuba-Ndaye A; Baketana-Kinzonzi L; Matungulu-Biyala E; Mutombo-Lupola P; Seghers CA; Smekens T; Ariën KK; Van Damme W; Kalk A; Peeters M; Ahuka-Mundeke S; Muyembe-Tamfum JJ; Vanlerberghe V J Health Popul Nutr; 2024 Jun; 43(1):74. PubMed ID: 38824595 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves. Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848 [TBL] [Abstract][Full Text] [Related]
15. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021. Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201 [TBL] [Abstract][Full Text] [Related]
16. Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic. Anand S; Montez-Rath M; Han J; Cadden L; Hunsader P; Kerschmann R; Beyer P; Boyd SD; Garcia P; Dittrich M; Block GA; Parsonnet J; Chertow GM JAMA Netw Open; 2021 Jul; 4(7):e2116572. PubMed ID: 34251441 [TBL] [Abstract][Full Text] [Related]